CAS 116836-41-0

Formula: C38H69NO13

InChI: InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1

InChI key: AGOYDEPGAOXOCK-KCBOHYOISA-N

SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O

(14R)-Hydroxy Clarithromycin

CAS: 116836-41-0

Formula: C₃₈H₆₉NO₁₄

Molecular weight: 763.96

Ref: 4Z-C-3740

(14R)-14-Hydroxy Clarithromycin

CAS: 116836-41-0

Formula: C₃₈H₆₉NO₁₄

Molecular weight: 763.96

Ref: ST-EA-CP-C1021

14-Hydroxy clarithromycin

CAS: 116836-41-0

14-Hydroxy clarithromycin is an analog of clarithromycin that has been shown to have anticancer properties. It is excreted in urine and has been found to inhibit several kinases, including cyclin-dependent kinases and protein kinase C. This drug induces apoptosis in cancer cells and inhibits tumor growth in Chinese hamsters. 14-Hydroxy clarithromycin has also been studied as a potential inhibitor of the human kinase, which may have implications for the development of new cancer therapies. Overall, this drug shows promise as an effective anticancer agent with potential for further research and development.

Formula: C₃₈H₆₉NO₁₃

Purity: Min. 95%

Molecular weight: 748 g/mol

Ref: 3D-REA83641